ATE474921T1 - Fucosetransporter - Google Patents

Fucosetransporter

Info

Publication number
ATE474921T1
ATE474921T1 AT04746425T AT04746425T ATE474921T1 AT E474921 T1 ATE474921 T1 AT E474921T1 AT 04746425 T AT04746425 T AT 04746425T AT 04746425 T AT04746425 T AT 04746425T AT E474921 T1 ATE474921 T1 AT E474921T1
Authority
AT
Austria
Prior art keywords
fucose
cell
golgi apparatus
existing
transporter
Prior art date
Application number
AT04746425T
Other languages
English (en)
Inventor
Masayuki Tsuchiya
Shigeyuki Iijima
Izumi Sugo
Yasuo Sekimori
Kenju Ueno
Kiyoshi Habu
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE474921T1 publication Critical patent/ATE474921T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04746425T 2003-06-18 2004-06-18 Fucosetransporter ATE474921T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2003174010 2003-06-18
JP2003174006 2003-06-18
JP2003282081 2003-07-29
JP2003282102 2003-07-29
PCT/JP2004/008956 WO2005017155A1 (ja) 2003-06-18 2004-06-18 フコーストランスポーター

Publications (1)

Publication Number Publication Date
ATE474921T1 true ATE474921T1 (de) 2010-08-15

Family

ID=34199142

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04746425T ATE474921T1 (de) 2003-06-18 2004-06-18 Fucosetransporter

Country Status (7)

Country Link
US (2) US7863042B2 (de)
EP (2) EP1642971B1 (de)
JP (1) JPWO2005017155A1 (de)
AT (1) ATE474921T1 (de)
DE (1) DE602004028249D1 (de)
ES (1) ES2348008T3 (de)
WO (1) WO2005017155A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332334B2 (en) 2003-04-18 2008-02-19 Oklahoma Medical Research Foundation Hematopoietic stem cells treated by in vitro fucosylation and methods of use
WO2005017155A1 (ja) 2003-06-18 2005-02-24 Chugai Seiyaku Kabushiki Kaisha フコーストランスポーター
US20090061485A1 (en) * 2004-12-22 2009-03-05 Chugai Seiyaku Kabushiki Kaisha Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited
US20090094042A1 (en) * 2007-10-09 2009-04-09 Mr. Gene Gmbh Method and System for Providing a Customer Biopolymer to a Customer
CA2723197C (en) * 2008-05-02 2017-09-19 Seattle Genetics, Inc. Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
WO2010119691A1 (ja) 2009-04-16 2010-10-21 国立大学法人東京大学 抗tmprss11e抗体を用いた癌の診断と治療
MY160680A (en) * 2009-09-22 2017-03-15 Probiogen Ag Process for producing molecules containing specialized glycan structures
TR201806936T4 (tr) 2010-01-29 2018-06-21 Chugai Pharmaceutical Co Ltd Anti-dll3 antikoru.
EP3513794A3 (de) 2010-08-05 2019-10-16 Seattle Genetics, Inc. Fucose-analoga für in-vivo-hemmung einer protein-fucosylierung
CA2882725C (en) 2012-08-23 2021-03-09 Regents Of The University Of Minnesota Treatment of sickle cell disease and inflammatory conditions
CN109735479B (zh) * 2019-01-30 2022-04-01 光明乳业股份有限公司 一种合成2’-岩藻糖基乳糖的重组枯草芽孢杆菌及其构建方法与应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0046742B1 (de) 1980-08-25 1984-06-27 KabiVitrum AB Peptidsubstrate zum Bestimmen der Proteaseaktivität
JPS58201994A (ja) 1982-05-21 1983-11-25 Hideaki Hagiwara 抗原特異的ヒト免疫グロブリンの生産方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
EP0239102A3 (de) 1986-03-28 1989-07-12 Tsuji, Kimiyoshi Verfahren zur Herstellung eines Human-Human-Hybridoms
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
WO1992020791A1 (en) 1990-07-10 1992-11-26 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
WO1992003918A1 (en) 1990-08-29 1992-03-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
AU665025B2 (en) 1991-09-23 1995-12-14 Cambridge Antibody Technology Limited Production of chimeric antibodies - a combinatorial approach
DK1136556T3 (da) 1991-11-25 2005-10-03 Enzon Inc Fremgangsmåde til fremstilling af multivalente antigen-bindende proteiner
ATE275198T1 (de) 1991-12-02 2004-09-15 Medical Res Council Herstellung von antikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken.
EP0746609A4 (de) 1991-12-17 1997-12-17 Genpharm Int Heterologe antikörper produzierende transgene nicht-humane tiere
EP0656941B1 (de) 1992-03-24 2005-06-01 Cambridge Antibody Technology Limited Verfahren zur herstellung von gliedern von spezifischen bindungspaaren
NZ255101A (en) 1992-07-24 1997-08-22 Cell Genesys Inc A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
FI91535C (fi) 1992-07-28 1994-07-11 Hurme Consulting Oy Menetelmä tiesuolan denaturoimiseksi ja denaturoitu tiesuola
EP0754225A4 (de) 1993-04-26 2001-01-31 Genpharm Int Heterologe antikörper produzierende transgene nicht-humane tiere
GB9313509D0 (en) 1993-06-30 1993-08-11 Medical Res Council Chemisynthetic libraries
AU690171B2 (en) 1993-12-03 1998-04-23 Medical Research Council Recombinant binding proteins and peptides
WO1996002576A1 (fr) 1994-07-13 1996-02-01 Chugai Seiyaku Kabushiki Kaisha Anticorps humain reconstitue contre l'interleukine-8 humaine
US6130364A (en) 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
EP1978033A3 (de) 1995-04-27 2008-12-24 Amgen Fremont Inc. Aus immunisiertem Xenomid abgeleitete menschliche Antikörper
CA2219486A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
FR2761994B1 (fr) 1997-04-11 1999-06-18 Centre Nat Rech Scient Preparation de recepteurs membranaires a partir de baculovirus extracellulaires
US7105315B2 (en) 1999-06-16 2006-09-12 Incyte Genomics, Inc. Transmembrane protein differentially expressed in cancer
JP2003525025A (ja) 1999-03-22 2003-08-26 インサイト・ファーマスーティカルズ・インコーポレイテッド ヒト膜貫通タンパク質
ES2571230T3 (es) 1999-04-09 2016-05-24 Kyowa Hakko Kirin Co Ltd Procedimiento para controlar la actividad de una molécula inmunofuncional
EP1396543A3 (de) * 1999-07-08 2004-03-31 Research Association for Biotechnology Primer zur Synthese von vollständigen cDNA Klonen und ihre Verwendung
US6908748B2 (en) 1999-07-29 2005-06-21 Kenji Sobue Genes associated with the maintenance of differentiation of smooth muscle cells
WO2001009316A1 (fr) 1999-07-29 2001-02-08 Helix Research Institute Nouveaux genes codant la proteine kinase / proteine phosphatase
EP1074617A3 (de) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
WO2001009345A1 (fr) 1999-07-29 2001-02-08 Helix Research Institute Nouveaux genes codant des proteines kinase et des proteines phosphatase
WO2001053312A1 (en) 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
JP5623683B2 (ja) 2000-03-22 2014-11-12 フィトン ホールディングス，リミティド ライアビリティ カンパニー 動物型糖鎖付加機能をもつ植物細胞
US20020197679A1 (en) 2000-06-20 2002-12-26 Tang Y. Tom Novel nucleic acids and polypeptides
CN102311986B (zh) 2000-10-06 2015-08-19 协和发酵麒麟株式会社 产生抗体组合物的细胞
AU2001295982A1 (en) 2000-10-20 2002-04-29 Chugai Seiyaku Kabushiki Kaisha Polybeta2 knockout animals
AU2003236020B2 (en) * 2002-04-09 2009-03-19 Kyowa Hakko Kirin Co., Ltd. Cell with depression or deletion of the activity of protein participating in GDP-fucose transport
WO2003085118A1 (fr) * 2002-04-09 2003-10-16 Kyowa Hakko Kogyo Co., Ltd. Procede de production de composition anticorps
WO2005017155A1 (ja) 2003-06-18 2005-02-24 Chugai Seiyaku Kabushiki Kaisha フコーストランスポーター
WO2006046751A1 (ja) * 2004-10-26 2006-05-04 Chugai Seiyaku Kabushiki Kaisha 糖鎖改変抗グリピカン３抗体
US20090061485A1 (en) * 2004-12-22 2009-03-05 Chugai Seiyaku Kabushiki Kaisha Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited

Also Published As

Publication number Publication date
WO2005017155A1 (ja) 2005-02-24
JPWO2005017155A1 (ja) 2006-10-12
EP1642971A1 (de) 2006-04-05
US20060246456A1 (en) 2006-11-02
ES2348008T3 (es) 2010-11-26
US7863042B2 (en) 2011-01-04
DE602004028249D1 (de) 2010-09-02
US20110070614A1 (en) 2011-03-24
EP1642971A4 (de) 2007-01-10
EP1642971B1 (de) 2010-07-21
EP2228445A1 (de) 2010-09-15

Similar Documents

Publication Publication Date Title
ATE474921T1 (de) Fucosetransporter
UA90846C2 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО, КОТОРОЕ СПЕЦИФИЧЕСКИ СВЯЗЫВАЕТСЯ С БЕТА-АМИЛОИДНЫМ ПЕПТИДОМ (Ab)
CY1122346T1 (el) Μονοκλωνα αντισωματα εναντι tης κλαουδινης 18 για τη θεραπεια του καρκινου
NL301089I2 (nl) imlifidase
MXPA05003887A (es) Antagonistas il - 15.
HK1131790A1 (en) High affinity human antibodies to human il-4 receptor
WO2006041934A3 (en) Methods and compositions for improving recombinant protein production
ECSP044978A (es) ANTICUERPOS HUMANOS ANTAGONISTAS CONTRA hTNFSF13b
ATE538203T1 (de) Für an der biosynthese von pladienolid beteiligtes polypeptid codierende dna
IL186265A0 (en) Il-21 variants
ATE430198T1 (de) Antikörperkonstruktion unter verwendung einer mrl/lpr-maus
GEP20094629B (en) Nogo receptor binding protein
WO2004048517A3 (en) Method for reducing or preventing modification of a polypeptide in solution
AU2002951409A0 (en) Methods for regulating cancer
DE602007009950D1 (de) Verwendung eines wachstumsstimulierenden proteins
DE60315815D1 (de) ANTAGONISTISCHE HUMANE ANTI-hFAS-LIGAND-ANTIKÖRPER UND FRAGMENTE DAVON
EE200500012A (et) Peptiid-pähine passiivne immunoteraapia ateroskleroosi raviks
WO2005123923A3 (en) Inducer specific tetracycline repressor proteins and methods of use thereof
DE60042487D1 (de) Methode und zusammensetzung zur angiogenese-inhibierung mit antagonisten gegen mmp-9 und beta1-integrine
AU2002341090A1 (en) Use of a protein of the crmp family for treating diseases related to the immune system
DE602006010990D1 (de) Verfahren zur dipeptidherstellung
WO2005019475A3 (en) Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)
ATE393170T1 (de) Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers
PL1863834T3 (pl) Polipeptydy i kodujące je kwasy nukleinowe
EP1677739A4 (de) Verfahren zur identifizierung von mitteln zur hemmung des wachstums von krebszellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties